TOFRANIL Drug Patent Profile
✉ Email this page to a colleague
When do Tofranil patents expire, and when can generic versions of Tofranil launch?
Tofranil is a drug marketed by Novartis and Specgx Llc and is included in three NDAs.
The generic ingredient in TOFRANIL is imipramine pamoate. There are thirty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tofranil
A generic version of TOFRANIL was approved as imipramine pamoate by HIKMA on April 16th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOFRANIL?
- What are the global sales for TOFRANIL?
- What is Average Wholesale Price for TOFRANIL?
Summary for TOFRANIL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 179 |
Clinical Trials: | 5 |
Patent Applications: | 3,853 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TOFRANIL at DailyMed |
![TOFRANIL drug patent expirations Drug patent expirations by year for TOFRANIL](/p/graph/s/t/TOFRANIL-patent-expirations.png)
Recent Clinical Trials for TOFRANIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sheppard Pratt Health System | N/A |
Central Michigan University | N/A |
Astellas Pharma Inc | N/A |
US Patents and Regulatory Information for TOFRANIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TOFRANIL | imipramine hydrochloride | INJECTABLE;INJECTION | 011838-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL | imipramine hydrochloride | TABLET;ORAL | 087846-001 | May 22, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |